“Teva’s CEO chose to give conservative guidance”
After giving a positive return in 2022, and in 2023 to date, Teva Pharmaceutical Industries (TASE: ...
Read moreTag: Tevas
Teva’s new CEO: There’s a possibility to return to progress
Yearly in January, US funding home JP Morgan holds a Healthcare Convention that pulls representatives of ...
Read more
Get the latest news and follow the coverage of Financial News, Stocks, Analysis, Trading Updates and more from the top trusted sources.